{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:37Z","timestamp":1790799997467,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cystic fibrosis is a hereditary metabolic disorder characterized by impaired traffic of chloride ions and water through membranes of the respiratory and gastrointestinal, that causes inadequate hydration of airway surfaces, dehydrated mucous secretions and a high-sodium chloride sweat. Although the classical presentation of the condition is well known, a better characterization of metabolic alterations related is need. In particular, the metabolic composition alterations of biological fluids may be influence by the disease state and could be captured as putative signature to set targeted therapeutic strategies. A targeted comprehensive mass spectrometry-based platform was employed to dissect the lipid content of saliva samples form CF patients, in order to investigate alterations in the lipid metabolic homeostasis related to the pathology, chronic obstructive pulmonary disease, <jats:italic>Pseudomonas Aeruginosa<\/jats:italic> infection, pancreatic insufficiency, liver disfunction and diabetes-related complications.<\/jats:p>","DOI":"10.1038\/s41598-022-24429-6","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T11:12:39Z","timestamp":1673521959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lipidomic alterations in human saliva from cystic fibrosis patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Marianna","family":"Caterino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carnovale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Iacotucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"24429_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn, J. S. Cystic fibrosis. Lancet 388, 2519\u20132531 (2016).","journal-title":"Lancet"},{"key":"24429_CR2","first-page":"517","volume":"70","author":"SD Freedman","year":"2002","unstructured":"Freedman, S. D., Blanco, P. G., Shea, J. C. & Alvarez, J. G. Analysis of lipid abnormalities in CF mice. Methods Mol. Med. 70, 517\u2013524 (2002).","journal-title":"Methods Mol. Med."},{"key":"24429_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0022-3476(94)70362-0","volume":"124","author":"WR Henderson","year":"1994","unstructured":"Henderson, W. R. et al. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J. Pediatr. 124, 400\u2013408 (1994).","journal-title":"J. Pediatr."},{"key":"24429_CR4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/cells9051197","volume":"9","author":"M Dei Cas","year":"2020","unstructured":"Dei Cas, M. et al. An innovative lipidomic workflow to investigate the lipid profile in a cystic fibrosis cell line. Cells 9, 1197 (2020).","journal-title":"Cells"},{"key":"24429_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1021\/acs.jproteome.0c00556","volume":"20","author":"A ZardiniBuzatto","year":"2021","unstructured":"ZardiniBuzatto, A. et al. Lipidome alterations induced by cystic fibrosis, CFTR mutation, and lung function. J. Proteome Res. 20, 549\u2013564 (2021).","journal-title":"J. Proteome Res."},{"key":"24429_CR6","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1515\/cclm-2015-1151","volume":"54","author":"M Gelzo","year":"2016","unstructured":"Gelzo, M. et al. Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: A preliminary study of plasma sterols. Clin. Chem. Lab. Med. 54, 1461\u20131466 (2016).","journal-title":"Clin. Chem. Lab. Med."},{"key":"24429_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245302","volume":"16","author":"F Amato","year":"2021","unstructured":"Amato, F. et al. Impaired cholesterol metabolism in the mouse model of cystic fibrosis: A preliminary study. PLoS ONE 16, e0245302 (2021).","journal-title":"PLoS ONE"},{"key":"24429_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1748","volume":"14","author":"V Teichgr\u00e4ber","year":"2008","unstructured":"Teichgr\u00e4ber, V. et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14, 382\u2013391 (2008).","journal-title":"Nat. Med."},{"key":"24429_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00677-20","volume":"89","author":"KA Becker","year":"2021","unstructured":"Becker, K. A. et al. Acid ceramidase rescues cystic fibrosis mice from pulmonary infections. Infect. Immun. 89, e00677 (2021).","journal-title":"Infect. Immun."},{"key":"24429_CR10","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.1073\/pnas.0401874101","volume":"101","author":"MR Wenk","year":"2004","unstructured":"Wenk, M. R. & De Camilli, P. Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: Insights from vesicle recycling in nerve terminals. Proc. Natl. Acad. Sci. USA. 101, 8262\u20138269 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"24429_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9210408","volume":"2016","author":"E Imperlini","year":"2016","unstructured":"Imperlini, E. et al. Mass spectrometry-based metabolomic and proteomic strategies in organic acidemias. Biomed Res. Int. 2016, 1\u201310 (2016).","journal-title":"Biomed Res. Int."},{"key":"24429_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nm0310-267","volume":"16","author":"E Gulbins","year":"2010","unstructured":"Gulbins, E. Lipids control mucus production in cystic fibrosis. Nat. Med. 16, 267\u2013268 (2010).","journal-title":"Nat. Med."},{"key":"24429_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrd1776","volume":"4","author":"MR Wenk","year":"2005","unstructured":"Wenk, M. R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594\u2013610 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"24429_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1440-1681.2005.04166.x","volume":"32","author":"TH Kee","year":"2005","unstructured":"Kee, T. H., Vit, P. & Melendez, A. J. Sphingosine kinase signalling in immune cells. Clin. Exp. Pharmacol. Physiol. 32, 153\u2013161 (2005).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"24429_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6741518","volume":"2019","author":"S Agatonovic-Kustrin","year":"2019","unstructured":"Agatonovic-Kustrin, S. et al. Analytical strategies in lipidomics for discovery of functional biomarkers from human saliva. Dis. Markers 2019, 1\u201310 (2019).","journal-title":"Dis. Markers"},{"key":"24429_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep25270","volume":"6","author":"V Capobianco","year":"2016","unstructured":"Capobianco, V. et al. Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity. Sci. Rep. 6, 1\u201310 (2016).","journal-title":"Sci. Rep."},{"key":"24429_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/diagnostics10040222","volume":"10","author":"A Castaldo","year":"2020","unstructured":"Castaldo, A. et al. Salivary cytokines and airways disease severity in patients with cystic fibrosis. Diagnostics 10, 222 (2020).","journal-title":"Diagnostics"},{"key":"24429_CR18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/diagnostics10110915","volume":"10","author":"M Gelzo","year":"2020","unstructured":"Gelzo, M. et al. Impaired ratio of unsaturated to saturated non-esterified fatty acids in saliva from patients with cystic fibrosis. Diagnostics 10, 915 (2020).","journal-title":"Diagnostics"},{"key":"24429_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-018-0766-6","volume":"18","author":"V Terlizzi","year":"2018","unstructured":"Terlizzi, V. et al. Clinical expression of cystic fibrosis in a large cohort of Italian siblings. BMC Pulm. Med. 18, 1\u20138 (2018).","journal-title":"BMC Pulm. Med."},{"key":"24429_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.chom.2017.05.001","volume":"21","author":"H Grassm\u00e9","year":"2017","unstructured":"Grassm\u00e9, H. et al. \u03b21-integrin accumulates in cystic fibrosis luminal airway epithelial membranes and decreases sphingosine, promoting bacterial infections. Cell Host Microbe 21, 707\u2013718 (2017).","journal-title":"Cell Host Microbe"},{"key":"24429_CR21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1164\/rccm.202001-0180OC","volume":"202","author":"AI Gardner","year":"2020","unstructured":"Gardner, A. I. et al. Recombinant acid ceramidase reduces inflammation and infection in cystic fibrosis. Am. J. Respir. Crit. Care Med. 202, 1133\u20131145 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"24429_CR22","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jcf.2019.04.012","volume":"18","author":"E Seidl","year":"2019","unstructured":"Seidl, E. et al. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. J. Cyst. Fibros. 18, 790\u2013795 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"24429_CR23","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1038\/sj.onc.1207146","volume":"22","author":"E Gulbins","year":"2003","unstructured":"Gulbins, E. & Kolesnick, R. Raft ceramide in molecular medicine. Oncogene 22, 7070\u20137077 (2003).","journal-title":"Oncogene"},{"key":"24429_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nm1238","volume":"11","author":"I Petrache","year":"2005","unstructured":"Petrache, I. et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat. Med. 11, 491\u2013498 (2005).","journal-title":"Nat. Med."},{"key":"24429_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1191\/1479972306cd111rs","volume":"3","author":"JS Elborn","year":"2006","unstructured":"Elborn, J. S. Practical management of cystic fibrosis. Chron. Respir. Dis. 3, 161\u2013165 (2006).","journal-title":"Chron. Respir. Dis."},{"key":"24429_CR26","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg, M., Haq, I. J., Polineni, D. & Davies, J. C. Cystic fibrosis. Lancet 397, 2195\u20132211 (2021).","journal-title":"Lancet"},{"key":"24429_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.plipres.2019.03.001","volume":"74","author":"D Gari\u0107","year":"2019","unstructured":"Gari\u0107, D., De Sanctis, J. B., Shah, J., Dumut, D. C. & Radzioch, D. Biochemistry of very-long-chain and long-chain ceramides in cystic fibrosis and other diseases: The importance of side chain. Prog. Lipid Res. 74, 130\u2013144 (2019).","journal-title":"Prog. Lipid Res."},{"key":"24429_CR28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1074-7613(03)00092-X","volume":"18","author":"DF Legler","year":"2003","unstructured":"Legler, D. F., Micheau, O., Doucey, M. A., Tschopp, J. & Bron, C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18, 655\u2013664 (2003).","journal-title":"Immunity"},{"key":"24429_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.bbrc.2013.03.032","volume":"434","author":"R Ziobro","year":"2013","unstructured":"Ziobro, R., Henry, B., Edwards, M. J., Lentsch, A. B. & Gulbins, E. Ceramide mediates lung fibrosis in cystic fibrosis. Biochem. Biophys. Res. Commun. 434, 705\u2013709 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"24429_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1730245","volume":"2017","author":"D Schiumarini","year":"2017","unstructured":"Schiumarini, D. et al. Evidence for the involvement of lipid rafts and plasma membrane sphingolipid hydrolases in Pseudomonas aeruginosa infection of cystic fibrosis bronchial epithelial cells. Mediators Inflamm. 2017, 1\u201310 (2017).","journal-title":"Mediators Inflamm."},{"key":"24429_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","volume":"1781","author":"C Mao","year":"2008","unstructured":"Mao, C. & Obeid, L. M. Ceramidases: Regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim. Biophys. Acta 1781, 424\u2013434 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"24429_CR32","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/cells9061379","volume":"9","author":"C Duarte","year":"2020","unstructured":"Duarte, C. et al. Elusive roles of the different ceramidases in human health, pathophysiology, and tissue regeneration. Cells 9, 1379 (2020).","journal-title":"Cells"},{"key":"24429_CR33","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1007\/s00018-020-03530-x","volume":"77","author":"D Gari\u0107","year":"2020","unstructured":"Gari\u0107, D., Dumut, D. C., Shah, J., De Sanctis, J. B. & Radzioch, D. The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. Cell. Mol. Life Sci. 77, 4255\u20134267 (2020).","journal-title":"Cell. Mol. Life Sci."},{"key":"24429_CR34","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jcf.2022.02.005","volume":"21","author":"D Westh\u00f6lter","year":"2022","unstructured":"Westh\u00f6lter, D. et al. CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis. J. Cyst. Fibros. 21, 713\u2013720 (2022).","journal-title":"J. Cyst. Fibros."},{"key":"24429_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cellsig.2016.09.010","volume":"29","author":"J Jacobi","year":"2017","unstructured":"Jacobi, J. et al. Targeting acid sphingomyelinase with anti-angiogenic chemotherapy. Cell. Signal. 29, 52\u201361 (2017).","journal-title":"Cell. Signal."},{"key":"24429_CR36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/ajcn\/75.6.1005","volume":"75","author":"V Figueroa","year":"2002","unstructured":"Figueroa, V., Milla, C., Parks, E. J., Schwarzenberg, S. J. & Moran, A. Abnormal lipid concentrations in cystic fibrosis. Am. J. Clin. Nutr. 75, 1005\u20131011 (2002).","journal-title":"Am. J. Clin. Nutr."},{"key":"24429_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jcf.2021.06.010","volume":"21","author":"JK Nowak","year":"2022","unstructured":"Nowak, J. K. et al. Preclinical atherosclerosis in cystic fibrosis: Two distinct presentations are related to pancreatic status. J. Cyst. Fibros. 21, 26\u201333 (2022).","journal-title":"J. Cyst. Fibros."},{"key":"24429_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcf.2012.08.012","volume":"12","author":"MC Ishimo","year":"2013","unstructured":"Ishimo, M. C. et al. Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients. J. Cyst. Fibros. 12, 271\u2013276 (2013).","journal-title":"J. Cyst. Fibros."},{"key":"24429_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1194\/jlr.P013722","volume":"52","author":"M Ollero","year":"2011","unstructured":"Ollero, M. et al. Plasma lipidomics reveals potential prognostic signatures within a cohort of cystic fibrosis patients. J. Lipid Res. 52, 1011\u20131022 (2011).","journal-title":"J. Lipid Res."},{"key":"24429_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1172\/JCI113046","volume":"80","author":"KR Feingold","year":"1987","unstructured":"Feingold, K. R. & Grunfeld, C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest. 80, 184\u2013190 (1987).","journal-title":"J. Clin. Invest."},{"key":"24429_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010446","volume":"5","author":"G Mailhot","year":"2010","unstructured":"Mailhot, G., Rabasa-Lhoret, R., Moreau, A., Berthiaume, Y. & Levy, E. CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2\/15 cells. PLoS ONE 5, e10446 (2010).","journal-title":"PLoS ONE"},{"key":"24429_CR42","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/j.jada.2007.09.005","volume":"107","author":"CM Gordon","year":"2007","unstructured":"Gordon, C. M. et al. Nutrient status of adults with cystic fibrosis. J. Am. Diet. Assoc. 107, 2114\u20132119 (2007).","journal-title":"J. Am. Diet. Assoc."},{"key":"24429_CR43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1055\/s-0039-3402723","volume":"38","author":"KH Schulpis","year":"2021","unstructured":"Schulpis, K. H. et al. Perinatal reduced blood concentrations of free carnitine and acylcarnitines in infants with cystic fibrosis. Am. J. Perinatol. 38, 828\u2013833 (2021).","journal-title":"Am. J. Perinatol."},{"key":"24429_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00005176-199411000-00010","volume":"19","author":"TA Kovesi","year":"1994","unstructured":"Kovesi, T. A., Lehotay, D. C. & Levison, H. Plasma carnitine levels in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 19, 421\u2013424 (1994).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"24429_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ppul.22859","volume":"49","author":"E Joseloff","year":"2014","unstructured":"Joseloff, E. et al. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis. Pediatr. Pulmonol. 49, 463\u2013472 (2014).","journal-title":"Pediatr. Pulmonol."},{"key":"24429_CR46","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/0024-3205(89)90389-5","volume":"44","author":"BL Shapiro","year":"1989","unstructured":"Shapiro, B. L. Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci. 44, 1327\u20131334 (1989).","journal-title":"Life Sci."},{"key":"24429_CR47","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/diagnostics10080570","volume":"10","author":"A Castaldo","year":"2020","unstructured":"Castaldo, A. et al. Cystic fibrosis-screening positive inconclusive diagnosis: Newborn screening and long-term follow-up permits to early identify patients with cftr-related disorders. Diagnostics 10, 570 (2020).","journal-title":"Diagnostics"},{"key":"24429_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","volume":"17","author":"C Castellani","year":"2018","unstructured":"Castellani, C. et al. ECFS best practice guidelines: The 2018 revision. J. Cyst. Fibros. 17, 153\u2013178 (2018).","journal-title":"J. Cyst. Fibros."},{"key":"24429_CR49","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1515\/cclm-2017-0553","volume":"56","author":"A Bergougnoux","year":"2018","unstructured":"Bergougnoux, A. et al. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology. Clin. Chem. Lab. Med. 56, 1046\u20131053 (2018).","journal-title":"Clin. Chem. Lab. Med."},{"key":"24429_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jmoldx.2011.09.001","volume":"14","author":"F Amato","year":"2012","unstructured":"Amato, F. et al. Extensive molecular analysis of patients bearing CFTR-related disorders. J. Mol. Diagn. 14, 81\u201389 (2012).","journal-title":"J. Mol. Diagn."},{"key":"24429_CR51","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3\u201395-year age range: The global lung function 2012 equations. Eur. Respir. J. 40, 1324\u20131343 (2012).","journal-title":"Eur. Respir. J."},{"key":"24429_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164232","volume":"11","author":"D Seidler","year":"2016","unstructured":"Seidler, D., Griffin, M., Nymon, A., Koeppen, K. & Ashare, A. Throat swabs and sputum culture as predictors of P. aeruginosa or S. aureus lung colonization in adult cystic fibrosis patients. PLoS ONE 11, e0164232 (2016).","journal-title":"PLoS ONE"},{"key":"24429_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","volume":"55","author":"VD Morinville","year":"2012","unstructured":"Morinville, V. D. et al. Definitions of pediatric pancreatitis and survey of present clinical practices. J. Pediatr. Gastroenterol. Nutr. 55, 261\u2013265 (2012).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"24429_CR54","doi-asserted-by":"publisher","first-page":"9548","DOI":"10.3390\/ijms22179548","volume":"22","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int. J. Mol. Sci. 22, 9548 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"24429_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50735-7","volume":"9","author":"R Auricchio","year":"2019","unstructured":"Auricchio, R. et al. A phospholipid profile at 4 months predicts the onset of celiac disease in at-risk infants. Sci. Rep. 9, 1\u201312 (2019).","journal-title":"Sci. Rep."},{"key":"24429_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/biom10030355","volume":"10","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale, V. et al. Proteomic analysis of mucopolysaccharidosis IIIB Mouse brain. Biomolecules 10, 355 (2020).","journal-title":"Biomolecules"},{"key":"24429_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-82426-7","volume":"11","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci. Rep. 11, 1\u201310 (2021).","journal-title":"Sci. Rep."},{"key":"24429_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22869-7","volume":"8","author":"M Ruoppolo","year":"2018","unstructured":"Ruoppolo, M. et al. Targeted metabolomic profiling in rat tissues reveals sex differences. Sci. Rep. 8, 1\u201312 (2018).","journal-title":"Sci. Rep."},{"key":"24429_CR59","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/ijms21020582","volume":"21","author":"M Caterino","year":"2020","unstructured":"Caterino, M. et al. Influence of sex on urinary organic acids: A cross-sectional study in children. Int. J. Mol. Sci. 21, 582 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"24429_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2020.106453","volume":"33","author":"M Costanzo","year":"2020","unstructured":"Costanzo, M. et al. Dataset of a comparative proteomics experiment in a methylmalonyl-CoA mutase knockout HEK 293 cell model. Data Br. 33, 106453 (2020).","journal-title":"Data Br."},{"key":"24429_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21124211","volume":"21","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale, V. et al. Targeted metabolomic analysis of a mucopolysaccharidosis IIIB mouse model reveals an imbalance of branched-chain amino acid and fatty acid metabolism. Int. J. Mol. Sci. 21, 1\u201321 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"24429_CR62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/metabo11030158","volume":"11","author":"M Caterino","year":"2021","unstructured":"Caterino, M. et al. Sex affects human premature neonates\u2019 blood metabolome according to gestational age, parenteral nutrition, and caffeine treatment. Metabolites 11, 158 (2021).","journal-title":"Metabolites"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24429-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24429-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T11:23:05Z","timestamp":1673522585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24429-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["24429"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24429-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"600"}}